Literature DB >> 17979843

Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease.

Bruce Beutler1.   

Abstract

Microbe recognition based on a small collection of germline-encoded receptors carries a hidden liability: the possibility that mutational changes in the proteome will lead to self-recognition. The risk of self-recognition is enhanced, because innate immune receptors display low specificity, as they are driven to accommodate heterogeneous signature molecules found in the microbial world. The proteome structure is globally constrained by the innate immune sensing apparatus to satisfy a proscription against self-reactivity. But accidents happen, and here it is proposed that mutations creating neo-ligands for innate immune receptors are the proximal cause of sterile inflammatory diseases, which in turn embody the selective pressure that constrains the proteome. Such mutations are predictably dominant and may occur in the germline and also in somatic cells (e.g. in lymphocytes), causing inflammatory effects upon clonal expansion. They may also account for the inflammatory character of selected neoplastic diseases. The neo-ligand hypothesis accounts for the heritability, ambiguous linkage characteristics, phenotypic heterogeneity, and natural history of diverse forms of sterile inflammation. It explains sterile inflammatory diseases as conditions in which aberrant immune signaling is caused by proteome encroachment upon the ligand-recognition space over which the innate immune system stands guard.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979843     DOI: 10.1111/j.1600-065X.2007.00577.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  32 in total

Review 1.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

2.  Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes.

Authors:  Lyssia Gruaz; Céline Delucinge-Vivier; Patrick Descombes; Jean-Michel Dayer; Danielle Burger
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

3.  Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever.

Authors:  Elzinandes L Azeredo; Patrícia C Neves-Souza; Allan R Alvarenga; Sônia R N I Reis; Amanda Torrentes-Carvalho; Sonia-Maris O Zagne; Rita M R Nogueira; Luzia M Oliveira-Pinto; Claire F Kubelka
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

4.  Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.

Authors:  Lijing Su; Ying Wang; Junmei Wang; Yuto Mifune; Matthew D Morin; Brian T Jones; Eva Marie Y Moresco; Dale L Boger; Bruce Beutler; Hong Zhang
Journal:  J Med Chem       Date:  2019-03-13       Impact factor: 7.446

Review 5.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04

6.  TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.

Authors:  Diana M Lim; Sneha Narasimhan; Carmen Z Michaylira; Mei-Lun Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

7.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

Review 8.  Toll-like receptors, wound healing, and carcinogenesis.

Authors:  Johannes Kluwe; Ali Mencin; Robert F Schwabe
Journal:  J Mol Med (Berl)       Date:  2008-12-17       Impact factor: 4.599

Review 9.  Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases.

Authors:  Bruce Beutler
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

10.  FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.

Authors:  Swati Bhattacharyya; Zenshiro Tamaki; Wenxia Wang; Monique Hinchcliff; Paul Hoover; Spiro Getsios; Eric S White; John Varga
Journal:  Sci Transl Med       Date:  2014-04-16       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.